Navigation Links
Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
Date:12/8/2008

icals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

     Contacts:  Jack Lief                             Mary Claire Duch
                President and CEO                     WeissComm Partners
                                                      Media Relat
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
2. Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
3. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
4. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
5. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
6. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
9. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
11. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 29, 2014 Top10BestSEOHosting.com has recently ... that FatCow, Hostgator and Bluehost are the best ... ) has been working in the hosting industry ... is connected to multiple GB connections to ensure ... disruptions to customers’ websites. The great thing is ...
(Date:8/28/2014)... August 28, 2014 Blood's Thicker Than Water ... money and family ties in the heart of the city. ... – a story about how disrespect caused two families to ... many streets. , The Yayo Boyz and the M.O.B. Boyz ... speechless and local onlookers in a silent terror. "Guerrilla," AKA ...
(Date:8/28/2014)... Arizona State University graduate student Anthony Gonzales, co-founder ... one of five finalists in Entrepreneur magazine’s 2014 College ... fourth consecutive year that an ASU student has been ... SafeSIPP, and JJ Tang, co-founder of Vantage Realized, were ... dominated the competition: Three of the five finalists were ...
(Date:8/28/2014)... 28, 2014 (HealthDay News) -- Arguments between parents may ... indicates. Parents in more than 200 families were ... At the end of each day, mothers and fathers ... with their children. On days when parents reported ... their children were also strained, according to the study ...
(Date:8/28/2014)... August 28, 2014 ABC television stars ... 49th MDA Show of Strength Telethon airing Sunday, Aug. ... to help raise funds and awareness to help save ... by muscle disease. , Viewers tuning into the 2014 ... heart-felt appeals and introductions from some of the network’s ...
Breaking Medicine News(10 mins):Health News:Best Suppliers of Affordable Hosting Products Introduced by Top10BestSEOHosting.com 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 3Health News:Parents' Fights May Strain Bonds With Their Kids 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4
... , Isolagen, Inc. Receives Delisting Notice from NYSE Amex , ... Amex: ILE ) today announced that on June ... wholly owned subsidiary, each filed a voluntary petition for reorganization ... the United States Bankruptcy Court for the District of Delaware ...
... ... Connextions and ConnextionsHealth , ... Orlando, FL (Vocus) June 16, 2009 -- Connextions Inc. today announced the appointment ... aspects of the organization,s operational performance, including achievement of key performance metrics for clients; ...
... Rehabilitation Device Enhances Freedom of Motion , , NEW ... rehabilitation patients are learning to correct their unsteady and unsafe gait ... therapeutic device that allows them more freedom of motion to walk ... patients who are unstable or too weak to walk without fear ...
... System Provides Information to Improve Quality of , Programs ... June 16 URAC , the leading ... International , a premier, global, independent accreditor of health ... management professionals. The uSPEQ(R)/URAC Participant Experience Survey for ...
... to begin operations in Seattle , , ... a national carrier of life and disability insurance and ... Administrative Services department in Seattle, Wa. , , ... certain capabilities, technology assets, and employees of a Seattle-based ...
... invasive test might spur more people to be screened, experts ... a less invasive option to colonoscopy, is an effective way ... risk of the disease because of family history or a ... However, the study, in the June 17 issue of the ...
Cached Medicine News:Health News:Isolagen, Inc. Announces Filing of Voluntary Petition Under Chapter 11 of the Bankruptcy Code 2Health News:Isolagen, Inc. Announces Filing of Voluntary Petition Under Chapter 11 of the Bankruptcy Code 3Health News:Connextions Inc. Bolsters Operational Capabilities With Addition Of Senior Business Process Outsouring Professional 2Health News:Connextions Inc. Bolsters Operational Capabilities With Addition Of Senior Business Process Outsouring Professional 3Health News:'Navigaitor' Helps Patients Walk Again 2Health News:'Navigaitor' Helps Patients Walk Again 3Health News:'Navigaitor' Helps Patients Walk Again 4Health News:'Navigaitor' Helps Patients Walk Again 5Health News:URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 2Health News:URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 3Health News:URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 4Health News:Assurant Employee Benefits Adds New Voluntary Capabilities 2Health News:For Some, Virtual Colonoscopy May Be Just As Good 2Health News:For Some, Virtual Colonoscopy May Be Just As Good 3
(Date:8/28/2014)... -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – ... - http://photos.prnewswire.com/prnh/20140828/140879 ) The ... Poland " an essential source of information and ... and provides insights into the demographic, regulatory, reimbursement ... provides valuable insights into the trends and segmentation ...
(Date:8/28/2014)... Aug. 28, 2014 Takeda Pharmaceutical Company ... commitment and submissions of data from a 10-year ... the United States (U.S.) Food and ... and the Japanese Ministry of Health, Labour, and ... Devices Agency (PMDA) for pioglitazone containing medicines, including ...
(Date:8/28/2014)... 28, 2014  In anticipation of the upcoming MEDevice ... available for the first time. Industry Overview: Medtech & ... offers a snapshot of San Diego,s ... from the latest employment statistics to current venture capital investment ... Diego such a vital part of the global ...
Breaking Medicine Technology:Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking....
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Acuity Vergence: Letter Acuity, Astigmatic,Clock, and Vergence Tests...
Medicine Products: